David dalla Vecchia

RFIDEA SA was launched in January 2003 under the name of Neuro Engineering. Its core business was focused on Traceability, Biotechnologies and Neural networks. In early 2004 it redefined its activity and decided to concentrate exclusively on electronic traceability. By the end of 2004 it had made its first round of fund rising and had changed name to reflect its commitment to the development of electronic identification technologies: RFIDEA RFIDEA received the prize for the 'Best Enterprise Project' at Enterprise 2004 ('Fonds des Jeunes Entrepreneurs' founded by the Roi Baudouin Foundation). Since the beginning, RFIDEA has been working with manufacturers in many sectors, such as food, pharmacy, metallurgy, chemistry, and automotive. It has worked with business leaders and with global organizations in charge of standard definitions.

AARDEX Group SA (Belgium) specializes in medication adherence solutions, offering user-friendly packaging for various types of medication, including injectables. The company is based in Belgium, specifically in Seraing, and has subsidiaries in Switzerland. The Belgian company's solutions have gained the trust of top biopharma companies, and they are known for creating the first-ever Medication Event Monitoring System (MEMS). The company was founded in 1984 by Professor John Urquhart and has been at the forefront of medication adherence technology ever since. Bernard Vrijens has been the CEO since 1984. AARDEX Group SA (Belgium was acquired by AARDEX Group SA/Management/ from WestRock Co. on February 18, 2018.

AARDEX Group (Switzerland) SA manufactures medication event monitoring systems. . The company was founded by Bernard Vrijens in 1984 and is headquarterd in Sion, Switzerland.